Bob Snyder

Bob Snyder is the Co-founder & Managing Director at Proteios Technology. Bob has also worked with BioTangent Diagnostics, LLC, University of Washington CoMotion, and the Institute of Translational Health Sciences (ITHS). Bob has over 25 years of experience in the medical device and diagnostics industry.

Bob Snyder’s journey in the medical device and diagnostics industry started in April 2013 when they became the President and Chief Executive Officer of MagnetoOrganics, LLC. Through their work at MagnetoOrganics, Bob was able to help deliver the right treatment to the right patient at the right time. In September 2016, Bob left MagnetoOrganics to join Proteios Technology as their Co-founder & Managing Director.

At Proteios Technology, Bob is working on a new generation of products that will help improve patient outcomes. The Proteios System is a novel, modular platform that enables real-time data collection from multiple body sites simultaneously. This system will provide clinicians with actionable insights to improve patient care.

Bob Snyder's educational career began with a Bachelor of Science in Chemistry from Humboldt State University. Bob then went on to earn a Doctor of Philosophy in Physical Biochemistry from UC Santa Barbara. Finally, they completed their education with a Master of Business Administration in Marketing and Finance from the University of Chicago Booth School of Business.

Alessio Ligabue - Principal Scientist, François Baneyx - Co-founder & Scientific Advisor, and Shanqiao Wei - Senior Scientist report to Bob Snyder.